Paul R. Sanberg, PhD, DSc, is Senior Vice President for Research, Innovation & Knowledge Enterprise at the University of South Florida and President of the National Academy of Inventors (NAI). His work has been instrumental in translating new pharmaceutical and cellular therapeutics to clinical trials and commercialization for Tourette syndrome, stroke, ALS, Alzheimer’s, Huntington’s and Parkinson’s disease, and he has significant biotech and pharmaceutical industry experience in these areas. He trained at York University, University of British Columbia, Australian National University and Johns Hopkins University School of Medicine; and held faculty appointments at University of Cincinnati and Brown University, among others. He is an inventor on 160 U.S. and foreign patents; author of over 660 scientific articles and 14 books, with over 32,000 citations; and editor-in-chief of Technology & Innovation. Awards include the Bryden Alumni Award (York University); Fulbright Specialist; McGovern Science & Society Award (Sigma Xi); Florida Academy of Sciences Medalist; Florida Inventors Hall of Fame inductee; Fellow of NAI, AAAS, AIMBE, Royal Societies of Chemistry, Public Health and Medicine; and AAAS-Lemelson Invention Ambassador. He serves on the nomination evaluation committee, U.S. National Medal of Technology and Innovation; and advisory board, APLU Commission on Innovation, Competitiveness, and Economic Prosperity.